IRONWOOD PHARMACEUTICALS, INC. Cash and Restricted Cash
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Cash and Restricted Cash of $79.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $79.13M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $220.47M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $215.46M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $140.41M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $79.13M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $220.47M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $215.46M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $140.41M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $92.85M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $108.48M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $88.56M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $88.21M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $105.52M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $121.54M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $92.15M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $111.46M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $176.62M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $742.08M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $657.94M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $575.92M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $506.10M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $595.11M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $621.86M 10-K · filed 2025-03-31 | |
| 2021-09-30 | $576.01M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $494.92M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $440.69M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $364.78M 10-K · filed 2024-02-16 | |
| 2020-09-30 | $309.77M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $255.47M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $233.36M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $179.24M 10-K · filed 2023-02-16 | |
| 2019-09-30 | $147.88M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $107.56M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $126.72M 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $180.85M 10-K · filed 2022-02-18 | |
| 2018-09-30 | $149.24M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $153.72M 10-Q · filed 2019-07-30 | |
| 2018-03-31 | $151.84M 10-Q · filed 2019-05-02 | |
| 2017-12-31 | $132.79M 10-K · filed 2021-02-17 | |
| 2017-09-30 | $169.70M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $189.19M 10-Q · filed 2018-08-06 | |
| 2017-03-31 | $141.57M 10-Q · filed 2018-05-04 | |
| 2016-12-31 | $62.25M 10-K · filed 2020-02-13 | $62.25M 10-Q · filed 2018-05-04 |
| 2015-12-31 | $270.03M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |